Of the medicines classed as “essential” by the World Health Organization (WHO), 90 percent are off patent, including treatments for…
While Eisai set the price of the drug at $26,500 a year in the US, the cost in Japan will…
This crisis, initially brought to light by patient advocates and news reports, is still raising concerns about a possible nationwide…
Sandoz has a leading global portfolio with eight marketed biosimilars and a further 25 assets in various stages of development.…
The virus can cause severe disease, including encephalitis (inflammation of the brain).
In 2021, the U.S. Food and Drug Administration (USFDA) first approved the drug for emergency use.
The G20 Leaders’ Declaration of 9 September 2023 under the Indian Presidency pledged to implement and prioritise tackling AMR by…
Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient…
Kerala schools resume outside containment zones as Nipah threat subsides; health officials report no new cases.
Dengue Outbreak in India: Delhi hospitals are seeing an increased footfall of dengue patients. It is noteworthy that the city’s…
Throughout this month-long event, diverse stakeholders are actively participating to improve ground-level nutrition outcomes and encourage behavioural changes.
This article will detail the differences among the various healthcare industries and which metrics investors should follow before making an…
Amid rises cases of dengue, precautionary measures are suggested along with timely medical assistance
According to the company’s statement, the acquisition of AMRI Hospitals offers a remarkable geographical fit for Manipal Hospitals.
Aflibercept had EU brand sales of approximately $1.8B for the 12 months ending December 31, 2022, according to IQVIA.
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries.
According to the company’s statement, it is a generic therapeutic equivalent version of (RLD), LEVOPHED injection of Hospira Inc.
Scrub Typhus in Odisha: A Joint Director and an epidemiologist have also been sent to both districts to investigate the…